CSHALS | |
United States - MA - Cambridge |
|
Hosted by: | ISCB |
Dates: | Feb 22, 2012 through Feb 24, 2012 |
Call for Proceedings Presentations: | 2011-08-29 through 2011-10-17 |
Call for Posters: | 2011-08-29 through 2012-01-29 |
Event Registration: | 2011-10-31 through 2011-01-01 |
Early Registration Deadline: | 2012-01-20 |
Description |
|
CSHALS is the premier annual event focused on the use of semantic technologies in the pharmaceutical industry, including hospitals/healthcare institutions and academic research labs. With an expanded scope that includes the emerging field of data science, CSHALS is the place to be in 2012! Rather than a Semantic Web conference, CSHALS focuses on specific applications of semantic technologies, and pays particular attention to data science product relevance. Attendees will gain a better understanding of where the field is headed and be prepared to advance with the field. As in past years, the 2011 conference was highly rated in the following areas: -Tutorial topics -Keynote speakers -Conference agenda -Conference logistics/organization Past attendee comments included… -"I thought the speakers were excellent." -"Well conducted in terms of bioinformatics technology." -"Terrific conference and I learned a lot – felt like I was able to contribute something as well." -"Very good mix, a bit futuristic … but highly necessary to keep exposing to less technology savvy folks." -"Cambridge (MA, USA) is a good location, with good transportation links to regional, national, and international attendees." 93% of the 2011 attendees will recommend this conference to others. CSHALS is your place to be in 2012! |
|
Additional Information | |
Event URL: | http://www.iscb.org/cshals2012 |
ISCB Member Discount: | 200 USD |
Contact Person: | Steven Leard ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.